SPOTLIGHT -
New Product Newswire for April 5, 2004
Miebo, First Prescription Eye Drop to Treat Tear Evaporation in Dry Eye Disease, Now Available
The perfluorohexyloctane ophthalmic solution from Bausch + Lomb was approved by the FDA in May and will have a whole acquisition cost of $771 for a one-month supply.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Sotagliflozin For Heart Failure Across Full Range of LVEF
The medication is broadly approved for heart failure with preserved or reduced ejection fraction.
FDA Approves First Oral Treatment for Patients With Moderate to Severe Crohn's Disease
The approval of Rinvoq (upadacitinib) was based on the results of three clinical trials: two induction therapy studies and one maintenance study.
FDA Approves Two Medications for Treatment of Schizophrenia
Otsuka America Pharmaceutical and Lundbeck’s Alify Asimtufii (aripiprazole) also was approved for maintenance monotherapy treatment of bipolar I disorder in adults.
FDA Approves Qalsody, First-of-its-Kind Treatment for Rare Form of ALS
The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).
